Camber Pharmaceuticals launches Dimethyl Fumarate DR capsules, the generic version of Tecfidera® capsules, which is indicated for the treatment of relapsing forms of multiple sclerosis.
Camber Pharmaceuticals is pleased to announce that it has launched Dimethyl Fumarate DR capsules, which is the generic version of Tecfidera® capsules, and is indicated for the treatment of relapsing forms of multiple sclerosis (MS).
Dimethyl Fumarate DR capsules are available from Camber in 120 mg-14ct and 240 mg-60 ct bottles as well as the 30-day Starter Kit that contains 120 mg-14 ct and 240 mg-46 ct bottles.
Camber Pharmaceuticals is a fully integrated international pharmaceutical company that maintains quality and integrity in all its products. Its parent company, Hetero Drugs of Hyderabad India, is one of the world’s leading API and finished dosage manufacturers. Camber’s commitment to the consumer is to bring the highest quality generic pharmaceuticals to the market to improve quality of life through cost-effective medications.
SOURCE: Camber Pharmaceuticals